INDIA bloc to hold key meeting today; SIR row, functioning of CEC on agenda

Morgan Stanley raises Lenskart target price to Rs 718; bull case implies 41% upside. Here’s why

Lenskart Solutions reported a 182.3% YoY rise in Q1 FY27 net profit to Rs 228 crore, while revenue grew 33.6% to Rs 2,214 crore. EBITDA margin improved to 21.7%, with growth across domestic and international markets. The company also reported strong demand for both affordable and premium eyewear, highlighting the scaling potential of its international business.

Anthropic CEO on AI aka Super Intelligence: 'We all need to come together and make it right'

"Much bigger than the Internet": Trump announces US to officially rename AI to 'Super Intelligence'

At a recent White House luncheon, President Trump announced the reclassification of Artificial Intelligence to Super Intelligence. He stated that an official document would be signed to formalize this change. The meeting included major tech executives, focusing on collaboration with local communities for data centers. Trump emphasized the importance of safety and responsible development of Super Intelligence technologies.

MTAR Tech among 4 stocks showing White Marubozu pattern

Four Nifty 500 stocks, including MTAR Technologies, Mankind Pharma, CMPDI, and PTC Industries, formed a White Marubozu bullish candlestick pattern on September 29. Technical data from StockEdge indicates strong upward momentum across these counters, as closing prices touched session highs, signaling sustained buying interest among market traders.

8 SME IPOs to open today, seek to raise Rs 440 crore; check price bands, lot sizes and key dates

Eight SME IPOs — TNA Solutions, Omara Ventures India, Sollfege Smart Electronics, Eventions, Acme India Industries, Paramount Syntex, SJP Ultrasonics and Dove Soft — open for subscription today, September 30, collectively seeking to raise around Rs 440 crore. Seven will list on BSE SME, while Eventions will debut on NSE SME.

BSE, Wipro shares in focus as stock exchange replaces IT major on Nifty 50 today. How much inflows, outflows to expect?

BSE will enter the Nifty 50, replacing Wipro in the semi-annual index rejig, potentially attracting $668 million in inflows. Wipro could face $230 million in outflows after exclusion. BSE has delivered strong long-term gains, while Wipro has declined sharply in 2026 amid pressure on Indian IT stocks and sector concerns.

From Zuckerberg, Pichai to Musk: Trump, tech titans sign AI pact; says industry can police itself

Rs 3,000 crore drugs seized from Iranian boat in Arabian Sea; 5 Pak nationals detained

The Indian Coast Guard conducted an operation on September 25, resulting in the seizure of significant drugs. Five Pakistani nationals were detained during this joint operation with Gujarat Anti-Terrorist Squad. The drugs, valued at over Rs 3,000 crore, were transported by an Iranian boat. This operation emphasized the commitment to preventing transnational drug trafficking in India's maritime areas.

Rs 3,000 crore drugs seized from Iranian boat in Arabian Sea; 5 Pak nationals detained

The Indian Coast Guard conducted an operation on September 25, resulting in the seizure of significant drugs. Five Pakistani nationals were detained during this joint operation with Gujarat Anti-Terrorist Squad. The drugs, valued at over Rs 3,000 crore, were transported by an Iranian boat. This operation emphasized the commitment to preventing transnational drug trafficking in India's maritime areas.

Lower Fed hike odds, oil dip lend RBI hand in supporting rupee

The rupee ⁠is expected to open at 95.94-95.99 per dollar, according to traders after closing Tuesday at 95.98

Bernstein cuts PB Fintech share price target by 53%. More pressure after Rs 37,000 m-cap rout?

PB Fintech shares have plunged 42% in four sessions, wiping out Rs 37,000 crore in market value, following IRDAI’s proposed reforms to curb dark patterns and rationalise insurance commissions. Bernstein, Jefferies and Morgan Stanley have flagged potential pressure on earnings, distribution economics and valuations, with brokerages highlighting risks to health insurance and the POSP business amid regulatory uncertainty.